Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-CTNNA1 Antibody (R3J64)

Catalog #:   RHE07502 Specific References (50) DATASHEET
Host species: Mouse
Isotype: IgG1
Applications: ELISA, IHC
Accession: P35221
Overview

Catalog No.

RHE07502

Species reactivity

Human

Host species

Mouse

Isotype

IgG1

Clonality

Monoclonal

Tested applications

ELISA: 1:10000, IHC: 1:200-1:1000

Target

Renal carcinoma antigen NY-REN-13, Catenin alpha-1, CTNNA1, Alpha E-catenin, Cadherin-associated protein

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P35221

Applications

ELISA, IHC

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% Sodium Azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

R3J64

Data Image
  • Immunohistochemical
    Immunohistochemical analysis of paraffin-embedded human stomach tissues using CTNNA1 mouse mAb with DAB staining.
References

The expression, localisation and interactome of pigeon CRY2., PMID:34645873

E-cadherin/α-catenin deregulated co-expression in thyroid carcinoma based on tissue microarray digital image analysis., PMID:27273957

Progressive chromatin repression and promoter methylation of CTNNA1 associated with advanced myeloid malignancies., PMID:19826047

Alpha-T-catenin (CTNNA3) gene was identified as a risk variant for toluene diisocyanate-induced asthma by genome-wide association analysis., PMID:19187332

Tissue microarray based analysis of prognostic markers in invasive bladder cancer: much effort to no avail?, PMID:18190825

p38 mitogen-activated protein kinase (MAPK) first regulates filamentous actin at the 8-16-cell stage during preimplantation development., PMID:15850458

Tumor-induced antibodies resemble the response to tissue damage., PMID:15700321

Vinculin controls PTEN protein level by maintaining the interaction of the adherens junction protein beta-catenin with the scaffolding protein MAGI-2., PMID:15579911

EpCAM is overexpressed in breast cancer and is a potential target for breast cancer gene therapy., PMID:15313925

E-cadherin and catenins in early squamous cervical carcinoma., PMID:15297198

Abnormal expression of E-cadherin in early gastric carcinoma: its relationship with macroscopic growth patterns and catenin alpha and beta., PMID:15128072

Disruption of cadherin/catenin expression, localization, and interactions during HgCl2-induced nephrotoxicity., PMID:15084754

Alpha-catenin is required for IGF-I-induced cellular migration but not invasion in human colonic cancer cells., PMID:14961074

Expression of alpha-catenin in alpha-catenin-deficient cells results in a reduced proliferation in three-dimensional multicellular spheroids but not in two-dimensional monolayer cultures., PMID:14755240

Immunohistochemical comparison of vascular and sinusoidal adherens junctions in cavernosal endothelium., PMID:14751392

E-cadherin-dependent intercellular adhesion enhances chemoresistance., PMID:14532995

Downregulation of E-cadherin and its undercoat proteins in pituitary growth hormone cell adenomas with prominent fibrous bodies., PMID:12665652

Effects of etodolac, a selective cyclooxygenase-2 inhibitor, on the expression of E-cadherin-catenin complexes in gastrointestinal cell lines., PMID:12483244

Targeting gene expression in the preimplantation mouse embryo using morpholino antisense oligonucleotides., PMID:12412042

Regulation of E-cadherin/catenin complex patterns by epidermal growth factor receptor modulation in human lung cancer cells., PMID:12057867

The mode of tumour progression in combined hepatocellular carcinoma and cholangiocarcinoma: an immunohistochemical analysis of E-cadherin, alpha-catenin and beta-catenin., PMID:11906618

Expression status of E-cadherin and alpha-, beta-, and gamma-catenins in thymoma., PMID:11899204

Evaluation of E-cadherin/catenin complex in primary and secondary glomerulonephritis., PMID:11877565

Structure and function of the N-cadherin/catenin complex in retinoblastoma., PMID:11867572

alpha-Catenin expression pattern and DNA image-analysis cytometry have no additional value over primary histology in clinical stage I nonseminomatous testicular cancer., PMID:11856111

Expression of E-cadherin-catenin complex in human benign schwannomas., PMID:11813884

Decreased expression of catenins (alpha and beta), p120 CTN, and E-cadherin cell adhesion proteins and E-cadherin gene promoter methylation in prostatic adenocarcinomas., PMID:11753952

Effects of hepatocyte growth factor on E-cadherin-mediated cell-cell adhesion in DU145 prostate cancer cells., PMID:11744496

Immunohistochemical analysis of E-cadherin, alpha-catenin, beta-catenin, gamma-catenin, and neural cell adhesion molecule (NCAM) in chordoma., PMID:11729215

The role of E-cadherin in the differentiation of gallbladder cancer cells., PMID:11683173

Co-downregulation of cell adhesion proteins alpha- and beta-catenins, p120CTN, E-cadherin, and CD44 in prostatic adenocarcinomas., PMID:11521230

Expression of alpha-catenin in alpha-catenin-deficient cells increases resistance to sphingosine-induced apoptosis., PMID:11489917

An intact overexpressed E-cadherin/alpha,beta-catenin axis characterizes the lymphovascular emboli of inflammatory breast carcinoma., PMID:11431364

Inflammatory bowel disease is associated with changes of enterocytic junctions., PMID:11408275

The expression of E-cadherin-catenin complex in adenoid cystic carcinoma of salivary glands., PMID:11314533

Caspase-dependent cleavage of cadherins and catenins during osteoblast apoptosis., PMID:11277264

Retention of the expression of E-cadherin and catenins is associated with shorter survival in grade III ductal carcinoma of the breast., PMID:11276001

A comparative study of the clinicopathological significance of E-cadherin and catenins (alpha, beta, gamma) expression in the surgical management of oral tongue carcinoma., PMID:11206273

Re-evaluation of epoxy resin sections for light and electron microscopic immunostaining., PMID:11181742

Truncation of the extracellular region abrogrates cell contact but retains the growth-suppressive activity of E-cadherin., PMID:11156412

Induction of invasion in vivo of alpha-catenin-positive HCT-8 human colon-cancer cells., PMID:11072244

E-cadherin and cadherin-associated cytoplasmic proteins are expressed in murine mast cells., PMID:11045574

Changes in E-cadherin associated with cytoplasmic molecules in well and poorly differentiated endometrial cancer., PMID:11027430

A role for E-cadherin in mouse primordial germ cell development., PMID:11023681

Expression of E-, P-, n-cadherins and catenins in human bladder carcinoma cell lines., PMID:10953163

Decreased expression of CD44, alpha-catenin, and deleted colon carcinoma and altered expression of beta-catenin in ulcerative colitis-associated dysplasia and carcinoma, as compared with sporadic colon neoplasms., PMID:10951334

Alterations in expression of cadherin-6 and E-cadherin during kidney development and in renal cell carcinoma., PMID:10940709

Molecular organization of tight and adherens junctions in the human placental vascular tree., PMID:10940205

Membrane type 1-matrix metalloproteinase expression is regulated by E-cadherin through the suppression of mitogen-activated protein kinase cascade., PMID:10936671

The organization of adherens junctions in mouse osteoblast-like cells (MC3T3-E1) and their modulation by triiodothyronine and 1,25-dihydroxyvitamin D3., PMID:10933223

Datasheet

Document Download

Anti-CTNNA1 Antibody (R3J64).pdf

 

$ 220
Product specifications
50 μg 220 100 μg 350

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-CTNNA1 Antibody (R3J64) [RHE07502]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only